Efficacy And Safety Of Glycopyrronium In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem1 Study

被引:0
|
作者
LaForce, C. [1 ]
Pearle, J. [2 ]
Feldman, G. [3 ]
Spangenthal, S. [4 ]
Eckert, J. H. [5 ]
Mota, F. [5 ]
Henley, M. [6 ]
D'Andrea, P. [6 ]
机构
[1] North Carolina Clin Res, Raleigh, NC USA
[2] Calif Res Med Grp Inc, Fullerton, CA USA
[3] S Carolina Pharmaceut Res, Spartanburg, SC USA
[4] Amer Hlth Res Charlotte, Charlotte, NC USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5745
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Comparison of efficacy and safety of twice-daily Glycopyrronium/Formoterol combination with once-daily Glycopyrronium in patients with moderate to severe COPD
    Salvi, Sundeep
    Kumar, Anand
    Agrawal, Sumit
    Leuva, Amrutlal
    Shukla, Vineet
    Deshpande, Shrikant
    Balamurugan, Santhalingum
    Singh, Ajeet
    Tikkiwal, Sharad
    Gupta, Sandeep
    Sawant, Sandesh
    Vaidya, Abhijit
    Gogtay, Jaideep
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [22] Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma
    Wechsler, Michael E.
    Ruddy, Marcella K.
    Pavord, Ian D.
    Israel, Elliot
    Rabe, Klaus F.
    Ford, Linda B.
    Maspero, Jorge F.
    Abdulai, Raolat M.
    Hu, Chih-Chi
    Martincova, Renata
    Jessel, Andreas
    Nivens, Michael C.
    Amin, Nikhil
    Weinreich, David M.
    Yancopoulos, George D.
    Goulaouic, Helene
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (18): : 1656 - 1668
  • [23] Effect of glycopyrronium vs tiotropium on pulmonary function and morning symptoms in patients with moderate-to-severe COPD: The SPRING study
    Ma Marin, Jose
    Clemens, Andreas
    Casamor, Ricard
    Castellani, Walter
    Schaper, Lennart
    Saralaya, Dinesh
    Gunstone, Anthony
    Kostikas, Konstantinos
    Aalamian-Mattheis, Maryam
    Beeh, Kai
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [24] Efficacy And Safety Of Aclidinium Bromide Compared With Tiotropium And Placebo In Patients With Moderate-To-Severe COPD: A Phase Iiib Study
    Beier, J.
    Kirsten, A.
    Mroz, R.
    Segarra, R.
    Chuecos, F.
    Caracta, C.
    Gil, E. Garcia
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [25] Safety Profile of Inhaled Glycopyrronium Twice Daily in Patients With Moderate-to-Severe COPD: Pooled Analysis From Four Clinical Trials
    Kerwin, Edward
    Pedinoff, Andrew
    Miller, S. David
    Franke-Bray, Brigitte
    Di Giovanni, Robert
    Henley, Michelle
    D'Andrea, Peter
    CHEST, 2015, 148 (04)
  • [26] Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
    Calverley, Peter M. A.
    Page, Clive
    Dal Negro, Roberto W.
    Fontana, Giovanni
    Cazzola, Mario
    Cicero, Arrigo F.
    Pozzi, Edoardo
    Wedzicha, Jadwiga A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 2733 - 2744
  • [27] A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study
    Lehmann, Sverre
    Ringbaek, Thomas
    Lokke, Anders
    Grote, Ludger
    Hedner, Jan
    Lindberg, Eva
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 199 - 210
  • [28] A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
    Salvi, Sundeep S.
    Vaidya, Abhijit J.
    Kodgule, Rahul R.
    Gogtay, Jaideep A.
    LUNG INDIA, 2016, 33 (03) : 272 - 277
  • [29] Efficacy and safety of intrauterine insemination in patients with moderate-to-severe endometriosis
    van der Houwen, Lisette E. E.
    Schreurs, Anneke M. F.
    Schats, Roel
    Heymans, Martijn W.
    Lambalk, Cornelis B.
    Hompes, Peter G. A.
    Mijatovic, Velja
    REPRODUCTIVE BIOMEDICINE ONLINE, 2014, 28 (05) : 590 - 598
  • [30] Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
    Hanania, Nicola A.
    Sethi, Sanjay
    Koltun, Arkady
    Ward, Jonathan K.
    Spanton, Jacqui
    Ng, Dik
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 117 - 127